Oral Imatinib Reduces Mortality in Hospitalized COVID-19 Patients Through Endothelial Barrier Protection and Immunomodulation

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: J. De Brabander 1, E. Duijvelaar 4, J.R. Schippers 4, P.J. Smeele 4, J. Duitman 3, J. Aman 4, H.J. Bogaard 4, T. van der Poll 1, L.D.J. Bos 2, CounterCOVID Study Group

Journal title: American Thoracic Society International Conference Abstracts

Journal publisher: American Thoracic Society

Published year: 2022

DOI identifier: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5049